University of Texas at Houston UT Houston Wins $30M for Genome-based Disease Studies The UT Health Sciences Center will use $26 million to study cardiovascular risks and $3 million for arthritis risk genes. Breaking News Diasorin Nabs FDA 510(k) Clearance for Gram-Negative Panel Protein Biomarkers May Predict Obese Patients at Risk of Liver Inflammation People in the News at Tempus AI, BostonGene, Biodesix, EnPlusOne Singleron, IHLAD Launch Middle East Joint Venture In Brief This Week: Chromatin Bioscience, Oxford Nanopore, Thermo Fisher, More
